Suicidal Ideation

• CLINICAL_TRIALS withdrawal · 2026-03-20
  Clinical Trial Update: Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies [Phase 2]

  A Phase 2 study on precision phenotyping of behavioral risk and response to electromagnetic and psychedelic therapies for suicidal ideation …

• CLINICAL_TRIALS withdrawal · 2025-09-08
  Clinical Trial Update: Brief DBT Skills Training for Coping With Suicidal Ideation [NA]

  This update reports that the clinical trial evaluating Brief DBT Skills Training for coping with suicidal ideation has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2025-02-13
  Clinical Trial Update: Improving Caregivers' Ability to Manage Life Stress [NA]

  A clinical trial examining caregivers' ability to manage life stress related to suicidal ideation has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2024-05-09
  Clinical Trial Update: Integration of PE & Coping Long-Term With Active Suicide Program for PTSD & Suicide Risk in Military Families [NA]

  This clinical trial evaluating prolonged exposure-based therapy plus coping strategies for PTSD and suicide risk in military families has be…

• CLINICAL_TRIALS withdrawal · 2023-11-14
  Clinical Trial Update: Anti-suicidal Effects of Buprenorphine In Depressed Individuals [Phase 3]

  A Phase 3 trial evaluating buprenorphine for anti-suicidal effects in depressed individuals has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2021-06-18
  Clinical Trial Update: Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder [Phase 4]

  Phase 4 trial investigating anti-suicidal effects of buprenorphine in opioid use disorder was withdrawn.

• CLINICAL_TRIALS withdrawal · 2017-03-03
  Clinical Trial Update: Intranasal Ketamine for Late-Life Depression and Suicidal Ideation [Phase 4]

  A Phase 4 clinical trial evaluating intranasal esketamine for late-life depression and suicidal ideation has been withdrawn.